Pharmathen International S.A.
PolandAll drugs from this manufacturer
-
Adifemu is used to treat relapsing-remitting multiple sclerosis (MS) in patients aged 13 years and older.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 120 mg ATC: L04AX07
-
The medicine is used for the treatment of relapsing-remitting multiple sclerosis (MS) in patients aged 13 years and older.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 240 mg ATC: L04AX07
-
The medicine is used in the treatment of bipolar affective depression, major depressive episodes, mania, and schizophrenia.
Dosage form: tablets, prolonged release
Active substance Dosage quetiapine fumarate 230.24 mg ATC: N05AH04
-
The medicine is used in the treatment of schizophrenia, mania, bipolar affective depression, and major depressive episodes.
Dosage form: tablets, prolonged release
Active substance Dosage quetiapine fumarate 345.36 mg ATC: N05AH04
-
The medicine is used in the treatment of schizophrenia, mania, bipolar affective depression, and major depressive episodes.
Dosage form: tablets, prolonged release
Active substance Dosage quetiapine fumarate 460.48 mg ATC: N05AH04
-
The medicine is used in adults and adolescents over 12 years of age to prevent nausea and vomiting induced by chemotherapy (cancer treatment).
Dosage form: capsules, hard
Active substance Dosage aprepitant 125 mg or 80 mg ATC: A04AD12
-
The medicine is used in adults for the treatment of relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom previous treatment has not been effective or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.
Dosage form: capsules, hard
Active substance Dosage fingolimod 0.5 mg ATC: L04AA27
-
The medicine is used in the treatment of depression (in the course of bipolar affective disorder or major depressive disorder), mania, and schizophrenia.
Dosage form: tablets, prolonged release
Active substance Dosage quetiapine 200 mg ATC: N05AH04
-
The medicine is used in the treatment of depression in bipolar disorder, major depressive episodes, mania, and schizophrenia.
Dosage form: tablets, prolonged release
Active substance Dosage quetiapine 300 mg ATC: N05AH04
-
The medicine is used in the treatment of depression in bipolar disorder, major depressive episodes, mania, and schizophrenia.
Dosage form: tablets, prolonged release
Active substance Dosage quetiapine 400 mg ATC: N05AH04
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, it is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 86.4808 mg ATC: B01AE07
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 126.8384 mg ATC: B01AE07
-
The medicine is used in adults to prevent the formation of blood clots in the brain and other blood vessels (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used for the treatment and prevention of recurrence of blood clots.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 172.9615 mg ATC: B01AE07
-
The medicine is used in adults for the treatment of depression, generalized anxiety disorder, and pain in diabetic neuropathy.
Dosage form: capsules, hard, intestinal
Active substance Dosage duloxetine 30 mg ATC: N06AX21
-
The medicine is intended for adults for the treatment of depression, generalized anxiety disorder, and pain in diabetic neuropathy.
Dosage form: capsules, hard, intestinal
Active substance Dosage duloxetine 60 mg ATC: N06AX21
-
The medicine is used in adults for the treatment of depression, generalized anxiety disorder, and pain resulting from diabetic neuropathy.
Dosage form: capsules, hard, intestinal
Active substance Dosage duloxetine hydrochloride 30 mg ATC: N06AX21
-
The medicine is used in adults for the treatment of depression, generalized anxiety disorder, and pain resulting from diabetic neuropathy.
Dosage form: capsules, hard, intestinal
Active substance Dosage duloxetine hydrochloride 60 mg ATC: N06AX21
-
The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients who have already been stabilized with paliperidone or risperidone.
Dosage form: suspension for injection with prolonged release
Active substance Dosage paliperidone 25 mg ATC: N05AX13
-
The medicine is used for the maintenance treatment of schizophrenia symptoms in adult patients who have been previously stabilized with paliperidone or risperidone.
Dosage form: suspension for injection with prolonged release
Active substance Dosage paliperidone 100 mg ATC: N05AX13
-
The medicine is intended for the treatment of adults with type 2 diabetes (non-insulin-dependent diabetes) when it cannot be controlled by diet and physical exercise alone, or when it is administered together with other diabetes medicines.
Dosage form: tablets, film-coated
Active substance Dosage vildagliptin 50 mg metformin hydrochloride 850 mg ATC: A10BD08
-
The medicine is intended for adult patients with type 2 diabetes (non-insulin-dependent diabetes) for whom diet and exercise are not sufficient to control blood sugar levels, or when the medicine is used in combination with other medicines (insulin or sulfonylurea derivatives).
Dosage form: tablets, film-coated
Active substance Dosage vildagliptin 50 mg metformin hydrochloride 1000 mg ATC: A10BD08
-
The medicine is used in adult patients with type 2 diabetes (non-insulin-dependent diabetes), when diet and physical exercise are insufficient or when used in combination with other medicines, such as insulin or sulfonylureas.
Dosage form: tablets, film-coated
Active substance Dosage vildagliptin 50 mg metformin hydrochloride 850 mg ATC: A10BD08
-
Ipinzan is used in adult patients with type 2 diabetes (non-insulin-dependent diabetes) when diet and exercise alone are not sufficient to control the disease, or when used in combination with other medications, such as insulin or sulfonylureas.
Dosage form: tablets, film-coated
Active substance Dosage vildagliptin 50 mg metformin hydrochloride 1000 mg ATC: A10BD08
-
The medicine is used in adults for the treatment of symptomatic stable angina pectoris (at a heart rate of 70 beats per minute or higher) and for the treatment of chronic heart failure (at a heart rate of 75 beats per minute or higher).
Dosage form: tablets, film-coated
Active substance Dosage ivabradine 5 mg ATC: C01EB17
-
The medicine is used in adults to treat the active form of rheumatoid arthritis and the active form of psoriatic arthropathy.
Dosage form: tablets, film-coated
Active substance Dosage leflunomide 10 mg ATC: L04AA13
-
The medicine is used in adults to treat active rheumatoid arthritis and active psoriatic arthropathy.
Dosage form: tablets, film-coated
Active substance Dosage leflunomide 15 mg ATC: L04AA13
-
The medicine is used in adult patients for the treatment of active rheumatoid arthritis and active psoriatic arthropathy.
Dosage form: tablets, film-coated
Active substance Dosage leflunomide 20 mg ATC: L04AA13
-
The medicine is used in adults to treat bacterial infections, such as sinusitis, acute exacerbation of chronic bronchitis, pneumonia (non-hospital cases), as well as mild to moderate upper respiratory tract infections. It may also be used to complete treatment for lung infections or skin and soft tissue infections if the medicine was previously administered as an intravenous infusion.
Dosage form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
-
The medicine is used to treat acromegaly, to relieve hot flashes and diarrhea in patients with neuroendocrine tumors, and to treat and inhibit the growth of certain advanced gastrointestinal endocrine tumors (GEP-NET) that cannot be surgically removed.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 66.67 mg ATC: H01CB03
-
The medicine is used for the treatment of acromegaly, for the relief of hot flashes and diarrhea in patients with neuroendocrine tumors, and for the treatment and inhibition of growth of certain advanced gastrointestinal neuroendocrine tumors (GEP-NETs) that cannot be surgically removed.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 100 mg ATC: H01CB03
-
The medicine is used for the treatment of acromegaly, to relieve symptoms such as hot flashes and diarrhea in patients with neuroendocrine tumors, and for the treatment and inhibition of growth of certain advanced gastrointestinal neuroendocrine tumors (GEP-NET) that cannot be surgically removed.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 133.33 mg ATC: H01CB03
-
This medicine is used in adults to prevent the formation of blood clots in hardened arteries. This helps to reduce the risk of serious events, such as a heart attack, stroke, or death, in people with atherosclerosis, peripheral artery disease, or after experiencing cardiovascular events.
Dosage form: tablets, film-coated
Active substance Dosage clopidogrel 112.1 mg ATC: B01AC04
-
The medicine is used in the treatment of schizophrenia, mania, and major depressive episodes in bipolar disorder.
Dosage form: tablets, prolonged release
Active substance Dosage quetiapine fumarate 600 mg ATC: N05AH04
-
The medicine is used in the treatment of Parkinson's disease. It helps relieve its symptoms by acting in the brain in a manner similar to naturally occurring dopamine.
Dosage form: tablets, prolonged release
Active substance Dosage ropinirole hydrochloride 2.28 mg ATC: N04BC04
-
It is used in the treatment of Parkinson's disease. It helps relieve its symptoms by acting in the brain in a manner similar to naturally occurring dopamine.
Dosage form: tablets, prolonged release
Active substance Dosage ropinirole hydrochloride 4.56 mg ATC: N04BC04
-
The medicine is used in the treatment of Parkinson's disease. It helps relieve its symptoms by acting in the brain in a manner similar to naturally occurring dopamine.
Dosage form: tablets, prolonged release
Active substance Dosage ropinirole hydrochloride 9.121 mg ATC: N04BC04
-
The medicinal product is used to treat adults as well as children and adolescents (over 10 years of age) with relapsing-remitting multiple sclerosis.
Dosage form: tablets, film-coated
Active substance Dosage teriflunomide 14 mg ATC: L04AK02
-
It is used to treat symptoms of overactive bladder syndrome, such as a sudden urge to urinate quickly, frequent urination, or inability to control urination.
Dosage form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 2 mg ATC: G04BD07
-
It is used to treat the symptoms of overactive bladder syndrome, such as a sudden urge to urinate quickly, frequent urination, or urinary incontinence.
Dosage form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 4 mg ATC: G04BD07
-
It is used to treat the symptoms of overactive bladder syndrome, such as a sudden urge to use the toilet quickly, frequent use of the toilet, or an inability to control urination.
Dosage form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 2 mg ATC: G04BD07
-
It is used to treat the symptoms of an overactive bladder, which is a situation where the patient cannot control urination or feels a sudden urge to use the toilet frequently.
Dosage form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 2 mg ATC: G04BD07
-
It is used to treat symptoms of an overactive bladder, such as a sudden urge to urinate, frequent urination, or loss of bladder control.
Dosage form: capsules, extended release, hard
Active substance Dosage tolterodine tartrate 4 mg ATC: G04BD07